Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2007

Open Access 01-12-2007 | Original Article

Chronic Illness with Complexity: Implications for Performance Measurement of Optimal Glycemic Control

Authors: Pramod Meduru, MD, MPH, Drew Helmer, MD, MS, Mangala Rajan, MBA, Chin-Lin Tseng, DrPH, Leonard Pogach, MD, MBA, Usha Sambamoorthi, PhD

Published in: Journal of General Internal Medicine | Special Issue 3/2007

Login to get access

Abstract

OBJECTIVE

To evaluate the association between chronic illness with complexity (CIC) and optimal glycemic control.

PARTICIPANTS

Cross-sectional and longitudinal analyses of Diabetes Epidemiologic Cohort database of Veterans Health Administration (VHA) users with diabetes, less than 75 years old, with HbA1c tests in fiscal year (FY) 1999 and 2000, alive at FY2000 end (N = 95,423).

DESIGN/MEASUREMENTS

Outcomes were HbA1c < 7% in each FY. CIC included three domains: nondiabetes physical illness, diabetes-related, and mental illness/substance abuse conditions. Other independent variables included age, gender, race, marital status, VHA priority status, and diabetes severity. Longitudinal analyses were restricted to patients with HbA1c ≥ 7% in FY1999 and included hospitalizations between final HbA1c’s in FY1999 and FY2000. Multiple logistic regressions examined associations between CIC categories and HbA1c.

RESULTS

In FY1999, 33% had HbA1c <7%. In multivariate analyses, patients with nondiabetes physical illness and mental illness/substance abuse were more likely to have HbA1c <7% in FY1999 [adjusted odds ratios for cancer (AOR), 1.31; 95% CI (1.25–1.37); mental illness only, 1.18; 95% CI (1.14–1.22)]. Those with diabetes-related complications were less likely to have HbA1c <7% in FY1999. Associations generally held in FY2000. However, conditions in the mental illness/substance abuse complexity domain were less strongly associated with HbA1c <7%. Macrovascular-related hospitalizations were positively associated with HbA1c <7% [AOR, 1.41; 95% CI (1.34–1.49)].

CONCLUSIONS

The association between CIC and HbA1c <7% is heterogeneous and depends on the domain of complexity. The varying associations of CIC categories with optimal glycemic control suggest the need for appropriate risk adjustment when using HbA1c <7% as a valid performance measure for diabetes quality of care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
2.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
4.
go back to reference National Committee for Quality Assurance. HEDIS 2007 Volume 2, Technical Manual. Washington DC, 2006. National Committee for Quality Assurance. HEDIS 2007 Volume 2, Technical Manual. Washington DC, 2006.
7.
go back to reference Berlowitz DR, Ash AS, Hickey EC, Kader B, Friedman R, Moskowitz MA. Profiling outcomes of ambulatory care: casemix affects perceived performance. Med Care. 1998;36:928–33.PubMedCrossRef Berlowitz DR, Ash AS, Hickey EC, Kader B, Friedman R, Moskowitz MA. Profiling outcomes of ambulatory care: casemix affects perceived performance. Med Care. 1998;36:928–33.PubMedCrossRef
8.
go back to reference Zhang Q, Safford M, Ottenweller J, et al. Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care. 2000;23:919–27.PubMedCrossRef Zhang Q, Safford M, Ottenweller J, et al. Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care. 2000;23:919–27.PubMedCrossRef
9.
go back to reference Weiner M, Long J. Cross-sectional versus longitudinal performance assessments in the management of diabetes. Med Care. 2004;42:II34–9.PubMed Weiner M, Long J. Cross-sectional versus longitudinal performance assessments in the management of diabetes. Med Care. 2004;42:II34–9.PubMed
10.
go back to reference Thompson W, Wang H, Xie M, et al. Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration. Health Serv Res. 2005;40:1818–35.PubMedCrossRef Thompson W, Wang H, Xie M, et al. Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration. Health Serv Res. 2005;40:1818–35.PubMedCrossRef
11.
go back to reference Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG. Quality of life, health status and clinical outcomes in Type 2 diabetes patients. Qual Life Res. 2007;16:165–77.PubMedCrossRef Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG. Quality of life, health status and clinical outcomes in Type 2 diabetes patients. Qual Life Res. 2007;16:165–77.PubMedCrossRef
12.
go back to reference De Rekeneire N, Resnick HE, Schwartz AV, et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care. 2003;26:3257–63.PubMedCrossRef De Rekeneire N, Resnick HE, Schwartz AV, et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care. 2003;26:3257–63.PubMedCrossRef
13.
go back to reference Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res. 2006;6:58.PubMedCrossRef Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res. 2006;6:58.PubMedCrossRef
14.
go back to reference Joish VN, Malone DC, Wendel C, Mohler MJ. Profiling quality of diabetes care in a Veterans Affairs Healthcare System. Am J Med Qual. 2004;19:112–20.PubMedCrossRef Joish VN, Malone DC, Wendel C, Mohler MJ. Profiling quality of diabetes care in a Veterans Affairs Healthcare System. Am J Med Qual. 2004;19:112–20.PubMedCrossRef
15.
go back to reference Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31.PubMedCrossRef Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31.PubMedCrossRef
16.
go back to reference Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165:2631–8.PubMedCrossRef Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165:2631–8.PubMedCrossRef
17.
go back to reference Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Veterans Health Administration based on computerized patient data. Diabetes Care. 2004;27:B10–21.PubMedCrossRef Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Veterans Health Administration based on computerized patient data. Diabetes Care. 2004;27:B10–21.PubMedCrossRef
18.
go back to reference Byrne MM, Kuebeler M, Pietz K, Petersen LA. Effect of using information from only one system for dually eligible health care users. Med Care. 2006;44:768–73.PubMedCrossRef Byrne MM, Kuebeler M, Pietz K, Petersen LA. Effect of using information from only one system for dually eligible health care users. Med Care. 2006;44:768–73.PubMedCrossRef
19.
go back to reference Kerr EA, Smith DM, Hogan MH, et al. Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures. Jt Comm J Qual Improv. 2002;28:555–65.PubMed Kerr EA, Smith DM, Hogan MH, et al. Comparing clinical automated, medical record, and hybrid data sources for diabetes quality measures. Jt Comm J Qual Improv. 2002;28:555–65.PubMed
20.
go back to reference Pogach L, Engelgau M, Aron D. Measuring progress toward achieving hemoglobin A1c goals in diabetes care: pass/fail or partial credit. JAMA. 2007;297:520–3.PubMedCrossRef Pogach L, Engelgau M, Aron D. Measuring progress toward achieving hemoglobin A1c goals in diabetes care: pass/fail or partial credit. JAMA. 2007;297:520–3.PubMedCrossRef
21.
go back to reference Selim AJ, Fincke G, Ren XS, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004;27:281–95.PubMed Selim AJ, Fincke G, Ren XS, et al. Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004;27:281–95.PubMed
22.
go back to reference Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24:1547–55.PubMedCrossRef Selby JV, Karter AJ, Ackerson LM, Ferrara A, Liu J. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care. 2001;24:1547–55.PubMedCrossRef
23.
go back to reference Reker DM, Rosen AK, Hoenig H, et al. The hazards of stroke case selection using administrative data. Med Care. 2002;40:96–104.PubMedCrossRef Reker DM, Rosen AK, Hoenig H, et al. The hazards of stroke case selection using administrative data. Med Care. 2002;40:96–104.PubMedCrossRef
24.
go back to reference Helmer DA, Tseng CL, Brimacombe M, Rajan M, Stiptzarov N, Pogach L. Applying diabetes-related prevention quality indicators to a national cohort of veterans with diabetes. Diabetes Care. 2003;26:3017–23.PubMedCrossRef Helmer DA, Tseng CL, Brimacombe M, Rajan M, Stiptzarov N, Pogach L. Applying diabetes-related prevention quality indicators to a national cohort of veterans with diabetes. Diabetes Care. 2003;26:3017–23.PubMedCrossRef
25.
go back to reference Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–12.PubMedCrossRef Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–12.PubMedCrossRef
26.
go back to reference Helmer D, Sambamoorthi U, Rajan M, Tiwari A, Pogach LM. A comparison of care quality between patients who rely on an integrated healthcare delivery system and those who obtain care outside the system. Annual meeting of the Society of General Internal Medicine, New Orleans, LA, May 2005. Helmer D, Sambamoorthi U, Rajan M, Tiwari A, Pogach LM. A comparison of care quality between patients who rely on an integrated healthcare delivery system and those who obtain care outside the system. Annual meeting of the Society of General Internal Medicine, New Orleans, LA, May 2005.
27.
go back to reference Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950–5.PubMedCrossRef Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950–5.PubMedCrossRef
28.
go back to reference Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421–31.PubMed Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421–31.PubMed
29.
go back to reference Pogach LM, Tiwari A, Maney M, Rajan M, Miller DR, Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? Am J Manag Care. 2007;13:133–40.PubMed Pogach LM, Tiwari A, Maney M, Rajan M, Miller DR, Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? Am J Manag Care. 2007;13:133–40.PubMed
30.
go back to reference Rathore SS, Wang Y, Radford MJ, Ordin DL, Krumholz HM. Quality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement? J Am Geriatr Soc. 2003;51:466–75.PubMedCrossRef Rathore SS, Wang Y, Radford MJ, Ordin DL, Krumholz HM. Quality of care of Medicare beneficiaries with acute myocardial infarction: who is included in quality improvement measurement? J Am Geriatr Soc. 2003;51:466–75.PubMedCrossRef
31.
go back to reference American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2006;29:S4–S42. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2006;29:S4–S42.
33.
go back to reference Brown AF, Mangione CM, Saliba D, Sarkisian CA. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51:S265–80.PubMedCrossRef Brown AF, Mangione CM, Saliba D, Sarkisian CA. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51:S265–80.PubMedCrossRef
Metadata
Title
Chronic Illness with Complexity: Implications for Performance Measurement of Optimal Glycemic Control
Authors
Pramod Meduru, MD, MPH
Drew Helmer, MD, MS
Mangala Rajan, MBA
Chin-Lin Tseng, DrPH
Leonard Pogach, MD, MBA
Usha Sambamoorthi, PhD
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue Special Issue 3/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0310-5

Other articles of this Special Issue 3/2007

Journal of General Internal Medicine 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.